Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
2 other identifiers
interventional
100
1 country
1
Brief Summary
The purpose of this research study is assess feasibility and acceptability of a recently developed brief self-help intervention targeted by cancer type to increase motivation to quit smoking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cancer
Started Aug 2024
Typical duration for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2024
CompletedFirst Posted
Study publicly available on registry
July 3, 2024
CompletedStudy Start
First participant enrolled
August 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2027
November 26, 2025
November 1, 2025
2.8 years
June 18, 2024
November 21, 2025
Conditions
Outcome Measures
Primary Outcomes (6)
Recruitment
Number of participants who consent to participate in the study
Baseline
Retention- Completion of 2-week follow-up
Number of participants who complete the 2-week follow-up assessment
2 weeks post-randomization
Retention- Completion of 1 month follow-up
Number of participants who complete the 1 month follow-up assessment
1 month post-randomization
Adherence- 2 weeks post-randomization
Number of participants who read the booklet 2 weeks post-randomization
2 weeks post-randomization
Adherence- 1 month post-randomization
Number of participants who read the booklet 1 month post-randomization
1 month post-randomization
Acceptability
Treatment satisfaction measured with 8 items adapted from the Client Satisfaction Questionnaire. Values between 8 and 32 with higher scores indicating higher satisfaction.
2 weeks post-randomization, 1 month post-randomization
Secondary Outcomes (4)
Motivation to quit smoking
Baseline, 2 weeks post-randomization, 1 month post-randomization
Treatment Engagement defined by the number of participants who enroll with the state tobacco quitline
2 weeks post-randomization, 1 month post-randomization
Smoking Status
2 weeks post-randomization, 1 month post-randomization]
Smoking Status
2 weeks post-randomization, 1 month post-randomization
Study Arms (2)
Usual Care
ACTIVE COMPARATORUsual Care + Targeted Self-Help Intervention
EXPERIMENTALInterventions
In addition to usual care participants will receive a self-help booklet specific for their cancer type. There are five booklets available, written at a 5-6th grade reading level and targeted by cancer type, that explain the connection between smoking and each cancer type, describe the benefits of quitting smoking after cancer, and address some of the barriers cancer patients face to quit smoking when fighting cancer. Each booklet also includes four testimonials inspired from conversations with patients.
Participants will receive the standard care typically offered for smoking cessation.
Eligibility Criteria
You may qualify if:
- Individuals who smoke and recently (i.e., within 6 months) received a diagnosis of breast, colorectal, gynecological, skin melanoma, or bladder cancer (n = 20 per cancer type). (Investigators will consider smokers individuals who report having smoked ≥1 cigarette in the past 30 days.)
- Able to read/write English;
- Able to give informed consent;
- Not currently enrolled in a smoking cessation program;
- Age ≥18 years old.
You may not qualify if:
- Male patients diagnosed with breast cancer will be excluded as lifetime risk for breast cancer in men is far below 1%
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Utahlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ursula Martinez, PhD
Huntsman Cancer Institute
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2024
First Posted
July 3, 2024
Study Start
August 28, 2024
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
July 1, 2027
Last Updated
November 26, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share